Kerecis selected to...

Reykjavik / Isafjordur, November 6, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will present at the Northern Future Forum in Helsinki November 7. The forum is the...

Kerecis to...

Reykjavik / Isafjordur, August 14, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will participate in the Military Health System Research Symposium (MHSRS) August 18...

Kerecis to Present...

Reykjavik / Isafjordur, May 23, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will participate in the NASDAQ OMX Iceland Prospect Conference on Tuesday, May 27, at...

Kerecis to...

Reykjavik / Isafjordur, May 5, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will demonstrate its MariGen Omega3 fish-skin surgical material at the 3rd nORBS (Nordic...

Fish-Skin Medical...

Kerecis to use US$2 million investment to further develop its tissue-regeneration technology Reykjavik / Isafjordur, Iceland, February 21, 2014 – Kerecis Limited, the emerging tissue-regeneration...

Kerecis Receives...

Patent protects fish-skin invention across multiple medical areas Reykjavik / Isafjordur, February 13th, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, has been...

Does Fish Skin...

University Hospital of Iceland and Kerecis to collaborate on medical research Reykjavik / Isafjordur, January 24, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, and...

FDA Clears...

New treatment option for the millions suffering from chronic wounds Reykjavik / Isafjordur, November 7, 2013 – Kerecis Limited announced today that a 510(k) clearance has been received from the...

Kerecis Establishes...

Reykjavik / Isafjordur, Iceland, August 8, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced the formation of a corporate scientific advisory board consisting of...

New Board Members...

Reykjavik / Isafjordur, Iceland, June 17, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced that Andri Sveinsson and Kristjan Johannesson have been appointed to the...